Order Article Reprints

Melhem MSC, Coelho VC, Fonseca CA, Oliveira Ld, Bonfietti LX, Szeszs MW, Magri MMC, Dorneles FS, Taguchi H, Moreira DVS, et al. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillusfumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values. Pharmaceutics. 2022; 14(10):2161. https://doi.org/10.3390/pharmaceutics14102161

Melhem, Marcia S. C., Vivian C. Coelho, Claudia A. Fonseca, Lidiane de Oliveira, Lucas X. Bonfietti, Maria. W. Szeszs, Marcello M. C. Magri, Francine S. Dorneles, Hideaki Taguchi, Daniel V. S. Moreira, and et al. 2022. "Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillusfumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values" Pharmaceutics 14, no. 10: 2161. https://doi.org/10.3390/pharmaceutics14102161

Melhem, M. S. C., Coelho, V. C., Fonseca, C. A., Oliveira, L. d., Bonfietti, L. X., Szeszs, M. W., Magri, M. M. C., Dorneles, F. S., Taguchi, H., Moreira, D. V. S., Motta, A. L., Batista, M. V., Kamei, K., & Shikanai-Yasuda, M. A. (2022). Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillusfumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values. Pharmaceutics, 14(10), 2161. https://doi.org/10.3390/pharmaceutics14102161